MedTrace Logo

Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset

NCT04962178 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2022-06-24

No results posted yet for this study

Summary

The primary objective of the trial is to evaluate the efficacy of early invasive strategy for STEMI patients within 24-48h of symptom onset.

Conditions

  • ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

PROCEDURE

Primary PCI

The patients assigned to early invasive strategy group will receive the primary PCI.

OTHER

Optimal medical therapy with primary PCI not performed

The patients assigned to conservative strategy group will receive optimal medical therapy before primary endpoint accomplished.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962178 on ClinicalTrials.gov